These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29727295)

  • 1. CROI 2018: Highlights of Viral Hepatitis.
    Luetkemeyer AF; Wyles DL
    Top Antivir Med; 2018 May; 26(1):30-38. PubMed ID: 29727295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CROI 2019: highlights of viral hepatitis.
    Luetkemeyer AF; Wyles DL
    Top Antivir Med; 2019 Apr; 27(1):41-49. PubMed ID: 31137002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
    Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
    Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
    Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.
    Sacks-Davis R; Doyle JS; Rauch A; Beguelin C; Pedrana AE; Matthews GV; Prins M; van der Valk M; Klein MB; Saeed S; Lacombe K; Chkhartishvili N; Altice FL; Hellard ME
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25051. PubMed ID: 29633559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CROI 2021: Viral Hepatitis and Other Forms of Liver Injury Impacting People with HIV.
    Luetkemeyer AF; Wyles DL
    Top Antivir Med; 2021; 29(3):379-385. PubMed ID: 34370419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CROI 2017: Highlights of Advances in Viral Hepatitis and Liver Fibrosis.
    Luetkemeyer AF; Wyles DL
    Top Antivir Med; 2017; 25(2):84-92. PubMed ID: 28598793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.
    Ingiliz P; Martin TC; Rodger A; Stellbrink HJ; Mauss S; Boesecke C; Mandorfer M; Bottero J; Baumgarten A; Bhagani S; Lacombe K; Nelson M; Rockstroh JK;
    J Hepatol; 2017 Feb; 66(2):282-287. PubMed ID: 27650285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliminating HIV/HCV co-infection in gay and bisexual men: is it achievable through scaling up treatment?
    Sacks-Davis R; Pedrana AE; Scott N; Doyle JS; Hellard ME
    Expert Rev Anti Infect Ther; 2018 May; 16(5):411-422. PubMed ID: 29722275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CROI 2015: Highlights of Viral Hepatitis Therapy.
    Luetkemeyer AF; Wyles DL
    Top Antivir Med; 2015; 23(1):66-76. PubMed ID: 25965313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
    Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
    BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C treatment as prevention: evidence, feasibility, and challenges.
    Hajarizadeh B; Grebely J; Martinello M; Matthews GV; Lloyd AR; Dore GJ
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):317-327. PubMed ID: 28404202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.